Poorly Soluble Drugs Dissolution and Drug Release

• Other Authors: Webster, Gregory K. (Editor), Jackson, J. Derek (Editor), Bell, Robert G. (Editor)
• Format: Manuscript Book
• Language: English
• Published: Singapore PAN STANFORD PUBLISHING 2017
• Series: Pan Stanford series on pharmaceutical analysis volume 1
• Subjects: Drug Liberation; Drug Delivery Systems; Solubility; Chemistry, Pharmaceutical
• Online Access: Click Here to View Status and Holdings.

 This book is the first text to provide a comprehensive assessment of the application of fundamental principles of dissolution and drug release testing to poorly soluble compounds and formulations. Such drug products are, vis-a-vis their physical and chemical properties, inherently incompatible with aqueous dissolution. However, dissolution methods are required for product development and selection, as well as for the fulfillment of regulatory obligations with respect to biopharmaceutical assessment and product quality understanding. The percentage of poorly soluble drugs, defined in classes 2 and 4 of the Biopharmaceutics Classification System (BCS), has significantly increased in the modern pharmaceutical development pipeline. This book provides a thorough exposition of general method development strategies for such drugs, including instrumentation and media selection, the use of compendial and non-compendial techniques in product development, and phase-appropriate approaches to dissolution development.